Advisory Shares
MSOS
US00768Y4531
AdvisorShares Pure US Cannabis ETF
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Synthetic Replication Note (Swap ETF)

Synthetic (Swap)

The reported holdings, valuation ratios (P/E, etc.), and analyst estimates reflect the fund's underlying collateral/substitute basket, not the actual composition of the tracked index.

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
12.81
Weighted Fwd P/E
-174.31
Avg P/FCF
17.58
Avg FCF Yield
5.45%
Avg EV / EBITDA
13.95
Avg EV / Revenue
2.44
Avg Price-to-Book (P/B)
1.76
Avg Price-to-Sales (P/S)
1.88
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-1,460.55%
Avg Debt-to-Equity (D/E)
109.57%
<50% (30.35%) 50-150% (54.07%) >150% (13.32%) Unreported (2.26%)

Profitability Analysis

14 Holdings Count
Profitable 46.28%
Profitable 46.28%
4 Holdings Count (28.57%)
Unprofitable 53.72%
10 Holdings Count (71.43%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
61.3%
Top 10
63.3%
Top 25
63.7%
50% Threshold
Top 3
The top 10 holdings account for 63.3% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

2 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (14.6%+)
High (38.1%+)
Top (52.7%+)

Country Breakdown

Max: 58.55%
US US US
58.55%
CA CA CA
3.98%

Sector Distribution

3 Sector
Healthcare
62.12%
Unknown
1.13%
Consumer Defensive
0.41%

Industry Distribution

3 Industries
Drug Manufacturers - Specialty & Generic
62.12%
Unknown
1.13%
Farm Products
0.41%

Market Cap Distribution

16 Holdings Count
Mid Cap (2B - 10B)
(1) 27.79%
Small / Micro Cap (< 2B)
(12) 34.74%
Unclassified
(3) 1.13%
ende